RVL Pharmaceuticals plc Intangible Assets, Gross (Excluding Goodwill)
RVL Pharmaceuticals plc had Intangible Assets, Gross (Excluding Goodwill) of $35.09 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Goodwill and Other
us-gaap:IntangibleAssetsGrossExcludingGoodwill · last filed 2021-11-15
- 2021-09-30: Intangible Assets, Gross (Excluding Goodwill) $35.09M.
- 2021-06-30: Intangible Assets, Gross (Excluding Goodwill) $35.09M.
- 2021-03-31: Intangible Assets, Gross (Excluding Goodwill) $294.05M.
- 2020-12-31: Intangible Assets, Gross (Excluding Goodwill) $64.00M; Intangible Assets, Gross (Excluding Goodwill) as first filed $366.23M.
| Period end | Intangible Assets, Gross (Excluding Goodwill) | Intangible Assets, Gross (Excluding Goodwill) as first filed |
|---|---|---|
| 2021-09-30 | $35.09M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $35.09M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $294.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $64.00M 10-Q · filed 2021-11-15 | $366.23M 10-K · filed 2021-03-30 |
| 2020-09-30 | $366.23M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $366.23M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $366.23M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $83.70M 8-K · filed 2021-09-08 | $649.98M 10-K · filed 2020-03-19 |
| 2019-09-30 | $649.98M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $649.98M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $649.98M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $667.88M 10-K · filed 2020-03-19 | $667.88M 10-K · filed 2019-03-28 |
| 2018-09-30 | $667.88M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $740.40M 8-K · filed 2019-12-20 |